Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy. Global cabazitaxel production regions are mainly distributed in USA and Europe. There is no doubt that USA is the largest production region in the world. In the future, we predict that there will be more and more cabazitaxel suppliers as soon as Sanofi’s Cabazitaxel patent expired. By 2024, global production will be 1427.4 Kg.
Currently, there are four major cabazitaxel API suppliers globally, including Sanofi, Tapi Teva, Fuan Pharmaceutical Group and Fujian Yewpark Biological etc. Sanofi is the global leader in this industry. According to our research, Sanofi had provided 845.8 Kg cabazitaxel API in 2017, which account for 95.32% of global market.
The report details the trend, potential and market size of Cabazitaxel market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cabazitaxelmarket, defines the market attractiveness level of Cabazitaxel market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cabazitaxel industry, describes the types of Cabazitaxel market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cabazitaxel market and the development prospects and opportunities of Cabazitaxel industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cabazitaxel market in Chapter 13.
By Player:
Sanofi
Tapi Teva
Fuan Pharmaceutical Group
Fujian Yewpark Biological
By Type:
Purity above 99%
Other Purity
By End-User:
Age Below 65
Age Above 65
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cabazitaxel Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cabazitaxel Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cabazitaxel Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cabazitaxel Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cabazitaxel Market Analysis and Outlook to 2022
-
7.1 Global Cabazitaxel Consumption (2017-2022)
-
7.2 United States Cabazitaxel Consumption (2017-2022)
-
7.3 Europe Cabazitaxel Consumption (2017-2022)
-
7.4 China Cabazitaxel Consumption (2017-2022)
-
7.5 Japan Cabazitaxel Consumption (2017-2022)
-
7.6 India Cabazitaxel Consumption (2017-2022)
-
7.7 South Korea Cabazitaxel Consumption (2017-2022)
8 Region and Country-wise Cabazitaxel Market Analysis and Outlook to 2028
-
8.1 Global Cabazitaxel Consumption Forecast (2022-2028)
-
8.2 United States Cabazitaxel Consumption Forecast (2022-2028)
-
8.3 Europe Cabazitaxel Consumption Forecast (2022-2028)
-
8.4 China Cabazitaxel Consumption Forecast (2022-2028)
-
8.5 Japan Cabazitaxel Consumption Forecast (2022-2028)
-
8.6 India Cabazitaxel Consumption Forecast (2022-2028)
-
8.7 South Korea Cabazitaxel Consumption Forecast (2022-2028)
9 Global Cabazitaxel Market Outlook by Types and Applications to 2022
-
9.1 Global Cabazitaxel Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Purity above 99% Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Other Purity Consumption and Growth Rate (2017-2022)
-
9.2 Global Cabazitaxel Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Age Below 65 Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Age Above 65 Consumption and Growth Rate (2017-2022)
10 Global Cabazitaxel Market Outlook by Types and Applications to 2028
-
10.1 Global Cabazitaxel Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Purity above 99% Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Other Purity Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cabazitaxel Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Age Below 65 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Age Above 65 Consumption Forecast and Growth Rate (2022-2028)
11 Global Cabazitaxel Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cabazitaxel Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cabazitaxel Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cabazitaxel Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cabazitaxel Market Competitive Analysis
-
14.1 Sanofi
-
14.1.1 Sanofi Company Details
-
14.1.2 Sanofi Cabazitaxel Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi Cabazitaxel Product and Service
-
14.2 Tapi Teva
-
14.2.1 Tapi Teva Company Details
-
14.2.2 Tapi Teva Cabazitaxel Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Tapi Teva Cabazitaxel Product and Service
-
14.3 Fuan Pharmaceutical Group
-
14.3.1 Fuan Pharmaceutical Group Company Details
-
14.3.2 Fuan Pharmaceutical Group Cabazitaxel Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Fuan Pharmaceutical Group Cabazitaxel Product and Service
-
14.4 Fujian Yewpark Biological
-
14.4.1 Fujian Yewpark Biological Company Details
-
14.4.2 Fujian Yewpark Biological Cabazitaxel Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Fujian Yewpark Biological Cabazitaxel Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cabazitaxel
-
Figure Cabazitaxel Picture
-
Table Global Cabazitaxel Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cabazitaxel Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cabazitaxel Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cabazitaxel Consumption by Country (2017-2022)
-
Figure United States Cabazitaxel Consumption and Growth Rate (2017-2022)
-
Table Europe Cabazitaxel Consumption and Growth Rate (2017-2022)
-
Figure China Cabazitaxel Consumption and Growth Rate (2017-2022)
-
Figure Japan Cabazitaxel Consumption and Growth Rate (2017-2022)
-
Figure India Cabazitaxel Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cabazitaxel Consumption and Growth Rate (2017-2022)
-
Figure Global Cabazitaxel Consumption Forecast by Country (2022-2028)
-
Figure United States Cabazitaxel Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cabazitaxel Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cabazitaxel Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cabazitaxel Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cabazitaxel Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cabazitaxel Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Purity above 99% Consumption and Growth Rate (2017-2022)
-
Figure Global Other Purity Consumption and Growth Rate (2017-2022)
-
Figure Global Age Below 65 Consumption and Growth Rate (2017-2022)
-
Figure Global Age Above 65 Consumption and Growth Rate (2017-2022)
-
Figure Global Purity above 99% Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Purity Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Age Below 65 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Age Above 65 Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cabazitaxel Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cabazitaxel Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Cabazitaxel Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Cabazitaxel Product and Service
-
Table Tapi Teva (Foundation Year, Company Profile and etc.)
-
Table Tapi Teva Cabazitaxel Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tapi Teva Cabazitaxel Product and Service
-
Table Fuan Pharmaceutical Group (Foundation Year, Company Profile and etc.)
-
Table Fuan Pharmaceutical Group Cabazitaxel Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fuan Pharmaceutical Group Cabazitaxel Product and Service
-
Table Fujian Yewpark Biological (Foundation Year, Company Profile and etc.)
-
Table Fujian Yewpark Biological Cabazitaxel Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fujian Yewpark Biological Cabazitaxel Product and Service
-
